CTOs on the Move

OraSure

www.orasure.com

 
OraSure Technologies empowers the global community to improve health and wellness by providing access to accurate, essential information. Together with its wholly-owned subsidiaries, DNA Genotek, Diversigen, and Novosanis, OraSure provides its customers with end-to-end solutions that encompass tools, services and diagnostics. The OraSure family of companies is a leader in the development, manufacture, and distribution of rapid diagnostic tests, sample collection and stabilization devices, and molecular services solutions designed to discover and detect critical medical conditions. OraSure`s portfolio of products is sold globally to clinical laboratories, hospitals, physician`s offices, clinics, public health and community-based organizations, research institutions, government agencies, pharma, ...
  • Number of Employees: 250-1000
  • Annual Revenue: $10-50 Million
  • www.orasure.com
  • 220 East First Street
    Bethlehem, PA USA 18015
  • Phone: 610.882.1820

Executives

Name Title Contact Details

Similar Companies

Specialized Engineering

Specialized Engineering is a Stockton, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

cambridge dental group

cambridge dental group is a Dearborn Heights, MI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Nepenthe Home Medical Equipment

Nepenthe Home Medical Equipment is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Mini Pharmacy Diabetes Supplies

Mini Pharmacy Diabetes Supplies is a Los Angeles, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Smith and Nephew

Smith & Nephew is a global advanced medical technology business. We support healthcare professionals in more than 100 countries to improve the quality of life for their patients. Since 1856, when our founder T.J. Smith developed a new method for refining cod liver oil, and in World War One when his nephew led the supply of wound care products, to the present day, Smith & Nephew continues to pioneer health solutions. Through our market leadership positions in Sports Medicine, Trauma, Orthopaedic Reconstruction and Advanced Wound Management, our 16,000 employees continue to improve outcomes and expand access, constantly striving to create value for healthcare professionals, patients, payers and shareholders. Annual sales in 2016 were more than $4.6 billion. We are a constituent of the UK’s FTSE100 and our shares are traded on London Stock Exchange and through American Depository Receipts on the New York Stock Exchange   We have leadership positions in Orthopaedic Reconstruction, Advanced Wound Management, Sports Medicine and Trauma.   We have almost 11,000 employees and a presence in more than 90 countries.   Annual sales in 2013 were more than $4.3 billion.   We are a constituent of the UK's FTSE100 and our shares are traded on the London Stock Exchange and through American Depository Receipts on the New York Stock Exchange (LSE: SN, NYSE: SNN)